Successful Deals with PwC: Adragos Pharma GmbH acquires Baccinex SA

We are pleased to announce that we have supported Adragos Pharma GmbH in its acquisition of a majority stake in Baccinex SA.

Adragos Pharma is a Contract Development and Manufacturing Organization (CDMO) based in Munich, Germany with manufacturing sites in Germany, Greece, Norway, France, and Japan. Adragos Pharma provides comprehensive pharmaceutical services supporting its international clients from initial product development and testing to commercial production.

Baccinex SA is a Swiss CDMO based in Courroux and specialises in clinical trial supplies and small-to-medium scale commercial production of liquid and lyophilized vials for pharmaceutical clients.

The transaction was announced on 25 November 2024.

PwC provided buy-side due diligence support (financial, tax and pension due diligence) as well as structuring and SPA advice to Adragos Pharma GmbH.

Please read the press release here.

The PwC team

Deals Financial

Luca Borrelli (Partner)
Maria Kashina (Manager)
Yali Xu (Senior Associate)

Deals Tax

Daniel Schmidt (Partner)
Oliver Humbel (Manager)
Klara Ivic (Senior Associate)
Christina Anna Leu (Associate)

Deals Pension

Adrian Jones (Partner)
Ester Lamerikx (Senior Manager)
David Stonebanks (Manager)
Wanda Szreder (Associate)

VAT

Daniela Heim-Schenker (Director)
Tobias Meier-Kern (Director)
Besart Vojka (Senior Associate)

Payroll Taxes

René Heinz (Senior Manager)
Stephen Turley (Director)